Potential utility of natural products as regulators of breast cancer-associated aromatase promoters
<p>Abstract</p> <p>Aromatase, the key enzyme in estrogen biosynthesis, converts androstenedione to estrone and testosterone to estradiol. The enzyme is expressed in various tissues such as ovary, placenta, bone, brain, skin, and adipose tissue. Aromatase enzyme is encoded by a sing...
Main Authors: | Walker Larry A, Khan Ikhlas A, Zhao Jianping, Khan Shabana I, Dasmahapatra Asok K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-06-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.rbej.com/content/9/1/91 |
Similar Items
-
Gene expression profiling and pathway analysis data in MCF-7 and MDA-MB-231 human breast cancer cell lines treated with dioscin
by: Pranapda Aumsuwan, et al.
Published: (2016-09-01) -
Clinical utilities of aromatase inhibitors in breast cancer
by: Chumsri S
Published: (2015-05-01) -
Effects of aromatase inhibitors on aromatase in breast
by: Vidya, Raghavan
Published: (2009) -
Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents
by: Vamshikrishna eManda, et al.
Published: (2014-08-01) -
Pathways regulating aromatase and cyclooxygenase gene expression in the normal and malignant breast /
by: Richards, Jeanette A.
Published: (2002)